Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1999
06/17/1999WO1999030157A2 Neuropilins in methods for diagnosis and prognosis of cancer
06/17/1999WO1999029906A2 Gene family with transformation modulating activity
06/17/1999WO1999029887A1 Dna encoding a mammalian lpa receptor and uses thereof
06/17/1999WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999WO1999029873A1 Cyclic gmp phosphodiesterase
06/17/1999WO1999029870A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999WO1999029869A1 Compounds and methods for the diagnosis and treatment of b. microti infection
06/17/1999WO1999029868A1 VACCINES FOR BLOCKING TRANSMISSION OF $i(PLASMODIUM VIVAX)
06/17/1999WO1999029865A2 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
06/17/1999WO1999029864A1 Recombinant vaccinia constructs expressing feline il-2, compositions and methods of use thereof
06/17/1999WO1999029863A1 Human interferon-epsilon: a type i interferon
06/17/1999WO1999029862A1 Synferon, a synthetic type i interferon
06/17/1999WO1999029861A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029859A1 Gene associated with neoplastic disease or malignancy associated gene
06/17/1999WO1999029858A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999WO1999029856A1 Restin and methods of use thereof
06/17/1999WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof
06/17/1999WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029852A1 High-affinity tryptophan transporter
06/17/1999WO1999029849A1 G-protein coupled receptors associated with immune response
06/17/1999WO1999029845A1 SEQUENCES CODING FOR kin17 PROTEIN AND THEIR APPLICATIONS
06/17/1999WO1999029844A2 Novel retroelements zam and idemfix, and their integrase
06/17/1999WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999WO1999029841A1 Purification and microsequencing of hyaluronidase isozymes
06/17/1999WO1999029838A1 Fibrinogen-converting enzyme hybrids
06/17/1999WO1999029814A2 Method of preparing lipoproteins, lipoaminoacids, lipid esters, and glucolipids from olive oil and/or its constituents which are condensed with vegetal protein hydrolysates or aminoacids or esterificated with fatty alcohols or sugars
06/17/1999WO1999029732A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999WO1999029731A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
06/17/1999WO1999029730A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999WO1999029729A2 Antagonists of neuropilin receptor function and use thereof
06/17/1999WO1999029727A1 Cyp7 promoter-binding factors
06/17/1999WO1999029726A1 Phospholipase inhibitor
06/17/1999WO1999029725A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5
06/17/1999WO1999029722A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4
06/17/1999WO1999029721A1 Anti-pathogen system and methods of use thereof
06/17/1999WO1999029719A2 Pancreatic-derived factors, and uses related thereto
06/17/1999WO1999029718A2 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
06/17/1999WO1999029717A2 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999WO1999029716A1 Echinocandin derivatives, preparation method and application as anti-fungal agents
06/17/1999WO1999029715A1 Tumor antigen peptide derivatives
06/17/1999WO1999029714A2 Organic chemical compounds and method for producing the same
06/17/1999WO1999029664A1 New compounds
06/17/1999WO1999029350A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999WO1999029345A1 Inhibition of tumor growth by macrophage intervention
06/17/1999WO1999029341A2 Methods for enhancement of protective immume responses employing leishmania polypeptides
06/17/1999WO1999029339A2 Prevention and/or treatment of allergic conditions
06/17/1999WO1999029338A1 Fibrinolytic inhibitor for sealant
06/17/1999WO1999029337A1 Stabilized teriparatide solutions
06/17/1999WO1999029336A1 Glp-1 formulations
06/17/1999WO1999029335A1 Pharmaceutical composition containing cyclosporin
06/17/1999WO1999029334A1 CtIP, A NOVEL PROTEIN THAT INTERACTS WITH CtBP AND USES THEREFOR
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999029311A1 Hiv/fiv protease inhibitors having a small p3 residue
06/17/1999WO1999029310A2 Regulation of t cell-mediated immunity by tryptophan and its analogs
06/17/1999WO1999029300A1 Self-emulsifying fenofibrate formulations
06/17/1999WO1999029279A2 Long-term survival and regeneration of central nervous system neurons
06/17/1999WO1999029182A1 Method for purifying heat shock peptides complexes
06/17/1999WO1999029173A1 Composition useful for providing one-step surgical preparation and drape
06/17/1999WO1999018216A3 Chimeric vaccine against tick-borne encephalitis virus
06/17/1999WO1999017801A3 Materials and methods relating to the stimulation of cells
06/17/1999WO1999017796A3 Modulation of lerk-2-mediated cell adhesion
06/17/1999WO1999017742A3 Taste masked formulations
06/17/1999WO1999016883A3 STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN
06/17/1999WO1999016460A3 Apolipoprotein e/growth factor complexes and methods of use
06/17/1999WO1999016426A3 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds
06/17/1999WO1999015554A3 Ras-like protein
06/17/1999WO1999015548A3 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
06/17/1999WO1999015198A3 Agents for combating bacterial meningitis
06/17/1999WO1999011298A3 Reverse phase connective tissue repair composition
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1999008109A9 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
06/17/1999WO1999007844A3 Methods and compositions for treatment of restenosis
06/17/1999WO1999007739A8 Dna encoding the human synapsin iii gene and uses thereof
06/17/1999WO1999000148A3 Method for treatment of spinal cord injuries in a mammal
06/17/1999WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response
06/17/1999WO1998055075A3 Compositions and methods for inhibiting photoaging of skin
06/17/1999WO1998018823A8 Ice inhibiting peptides
06/17/1999DE19755800A1 Cyclopeptidderivate Cyclopeptide derivatives
06/17/1999CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999CA2315273A1 Dna molecules encoding vertebrate nuclear receptor protein, nnr4
06/17/1999CA2314434A1 Dna molecules encoding human nuclear receptor protein, nnr5
06/17/1999CA2314267A1 Anti-pathogen system and methods of use thereof
06/17/1999CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999CA2313806A1 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999CA2313705A1 Restin and methods of use thereof
06/17/1999CA2313607A1 Antagonists of neuropilin receptor function and use thereof
06/17/1999CA2313451A1 Cyclic gmp phosphodiesterase
06/17/1999CA2313450A1 G-protein coupled receptors associated with immune response
06/17/1999CA2313405A1 Fibrinolytic inhibitor for sealant
06/17/1999CA2313390A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999CA2313381A1 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
06/17/1999CA2313350A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999CA2313348A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
06/17/1999CA2312698A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999CA2312476A1 Fibrinogen-converting enzyme hybrids
06/17/1999CA2312289A1 Tumor antigen peptide derivatives
1 ... 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 ... 3163